Pharmaceutical value-added industrial output growth (half year)
RecordSTO-YABFYJCS9A-QZNP55ZF5P-6GHRNW
China · January–June 2026
Pharmaceutical value-added industrial output growth in China (half year) was 6.4% in January–June 2026 (State Council).
Pharmaceutical value-added industrial output growth (half year): every country and year, and how it is measured
- Publisher
- State Council
- Authority tier
- T1 Official
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
From January to June, value-added industrial output of major pharmaceutical enterprises rose 6.4 percent year on year, with biopharmaceuticals posting double-digit growth.
Checked: the figure 6.4%is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
State Council of China. (2026). Value of China's innovative drug out-licensing deals hit new high in H1. Retrieved September 17, 2026, from https://english.www.gov.cn/archive/statistics/202607/20/content_WS6a5de696c6d00ca5f9a0c514.html. Via StatOrigin, https://statorigin.org/stat/stat_YABFYJCS9AQZNP55ZF5P6GHRNW
Other formats: MLA, Chicago, BibTeX
- MLA
- State Council of China. "Value of China's innovative drug out-licensing deals hit new high in H1." 2026, https://english.www.gov.cn/archive/statistics/202607/20/content_WS6a5de696c6d00ca5f9a0c514.html. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_YABFYJCS9AQZNP55ZF5P6GHRNW.
- Chicago
- State Council of China. "Value of China's innovative drug out-licensing deals hit new high in H1." 2026. https://english.www.gov.cn/archive/statistics/202607/20/content_WS6a5de696c6d00ca5f9a0c514.html. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_YABFYJCS9AQZNP55ZF5P6GHRNW.
- BibTeX
- @misc{statecouncil2026pharmaceutical6ghrnw, author = {{State Council of China}}, title = {Value of China's innovative drug out-licensing deals hit new high in H1}, year = {2026}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_YABFYJCS9AQZNP55ZF5P6GHRNW}, note = {Original source: https://english.www.gov.cn/archive/statistics/202607/20/content\_WS6a5de696c6d00ca5f9a0c514.html. Accessed September 17, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- State Council of China · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- Value of China's innovative drug out-licensing deals hit new high in H1
- Type
- Press release
- Published
- —
- Locator
- Value of China's innovative drug out-licensing deals hit new high in H1
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 26 September 2026
- Permanent URL
- /stat/stat_YABFYJCS9AQZNP55ZF5P6GHRNW